Relypsa Lands $10,000,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=099580a5-e4c1-4b2a-b007-3b37c82555d9&Preview=1 -
Date
3/11/2009 -
Company Name
Relypsa -
Mailing Address
5301 Patrick Henry Drive Santa Clara, CA 95054 -
Company Description
Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease. The company’s most advanced therapeutic programs include a novel potassium binder for treatment of hyperkalemia, known as ILY-105, as well as a novel sodium binder, ILY102, for the potential treatment of congestive heart failure. Relypsa is dedicated to discover additional product candidates through use of its proprietary polymer platform. -
Website
http://www.relypsa.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
5AM Ventures -
Venture Investor
New Leaf Venture Partners -
Venture Investor
Sprout Group -
Venture Investor
Delphi Ventures -
Venture Investor
CMEA Ventures -
Venture Investor
Mediphase Venture Partners
